A human homeobox gene, HB24, inhibits development of CD4+ T cells and impairs thymic involution in transgenic mice
The HB24 gene encodes a diverged human homeodomain-containing protein known to be expressed in hematopoietic progenitors and activated lymphocytes. We have generated transgenic mice that express HB24 under the control of the T cell receptor beta chain promoter/enhancer. Analysis of T cells and thymo...
Saved in:
Published in | The Journal of biological chemistry Vol. 268; no. 5; pp. 3646 - 3653 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Bethesda, MD
American Society for Biochemistry and Molecular Biology
15.02.1993
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The HB24 gene encodes a diverged human homeodomain-containing protein known to be expressed in hematopoietic progenitors and
activated lymphocytes. We have generated transgenic mice that express HB24 under the control of the T cell receptor beta chain
promoter/enhancer. Analysis of T cells and thymocytes from the transgenic mice revealed a marked increase in activated cells
as assessed by cell size profiles and interleukin-2 receptor expression. Within the thymus these changes were most pronounced
in the CD4+CD8- subset. Strikingly, the normal development of CD4+ T cells in the transgenic mice was impaired. Single positive
CD4 cells were reduced 35% in the thymus, and CD4+ T cells were reduced 90% in the spleen and lymph nodes compared to the
controls. Similar findings were found both in young mice (6 weeks old) and in more elderly mice (1 y old). However, the thymuses
of the elderly mice failed to undergo normal involution. Sera from HB24 transgenic mice had levels of IgG1 10-100-fold lower
than sera from matched controls, most likely as a consequence of the decrease in CD4+ T cells. These transgenic mice provide
a useful model for studying the role of HB24 in lymphocyte activation as well as for understanding the effects of abnormal
T cell activation on thymic and T cell development. |
---|---|
ISSN: | 0021-9258 1083-351X |
DOI: | 10.1016/S0021-9258(18)53742-X |